Core Laboratories differentiates itself through specialized technical expertise in reservoir characterization and production optimization, serving major oil and gas operators. The company maintains a geographically diversified revenue base, though Q1 2026 results highlighted vulnerability to geopolitical disruptions and regional instability, which significantly impacted Middle East operations and project execution.
Cyborg Score Rationale
Core Laboratories demonstrates solid long-term positioning in specialized oil and gas services with a 10.7% operating margin (2025) and healthy ROIC of 9.8%, but near-term headwinds are material. Q1 2026 saw revenue of $121.8M (down 12% sequentially, flat year-over-year) and GAAP losses driven by Middle East geopolitical disruptions, travel constraints, and supply-chain challenges, with free cash flow compressed to $0.5M despite manageable debt levels.
Top Insights
Q1 2026 revenue declined to $121.8M (down 11.9% sequentially), pressured by Middle East conflict disruptions and severe weather in North America/Europe, signaling near-term operational headwinds and project delay risks.
Reservoir Description segment (67% of Q1 revenue) heavily international-dependent with 80% offshore sourcing; Middle East conflicts directly impacted field access and sample logistics, illustrating geographic concentration risk.
Free cash flow contracted sharply to $0.5M in Q1 2026 despite modest CapEx, reflecting working capital pressure from elevated DSOs (74 days) and inventory, while net debt rose to $94.2M with leverage at 1.2x—manageable but trending unfavorably.
Named Competitors
Schlumberger — Integrated oilfield services and digital solutions
Baker Hughes — Oilfield services, equipment, and pressure pumping
Halliburton — Integrated oilfield services and project management
Recent Developments
(March 2026) Management reduced Q1 2026 guidance due to Middle East geopolitical instability, client-driven project delays, travel constraints, and supply-chain disruptions
(April 2026) Reported Q1 2026 revenue of $121.8M with GAAP net loss of $0.8M and operating loss on environmental and asset write-downs
(May 2026) Guided Q2 2026 revenue to $123M–$131M with operating margins of 7% and EPS of $0.06–$0.12
Open the full interactive Core Laboratories Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.